Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-120 manufacturers

Filters

Filters

Filters , active

Country of origin : China
1 products found

pp-120

Tablets

Dossier type
CTD
Dossier status
Under development
Country of origin
China
GMP approvals
China
Comments
Indication: KRAS G12C-mutant advanced solid tumors, primarily non-small cell lung cancer (NSCLC) and potentially other KRAS-driven solid tumors in relapsed/refractory settings Clinical stage: Phase 1/2 clinical development Modality: Small molecule Mechanism / Target: Selective KRAS G12C covalent inhibitor, locking KRAS in its inactive GDP-bound state and suppressing downstream MAPK signaling (RAF–MEK–ERK pathway) Route / form: Oral tablet (expected solid oral formulation) Differentiation: Next-generation KRAS G12C inhibitor designed to overcome resistance mechanisms seen with first-wave KRAS inhibitors; aims for improved potency and durability of response in KRAS-driven tumors; potential combination backbone therapy with EGFR or MEK inhibitors
Manufacturer #39107

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.